Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 6
2004 2
2005 2
2006 1
2007 6
2008 5
2009 2
2010 4
2011 4
2012 5
2013 4
2014 7
2015 4
2016 8
2017 12
2018 7
2019 7
2020 7
2021 6
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

97 results
Results by year
Filters applied: . Clear all
Page 1
The role of pharmacogenomics in adverse drug reactions.
Cacabelos R, Cacabelos N, Carril JC. Cacabelos R, et al. Expert Rev Clin Pharmacol. 2019 May;12(5):407-442. doi: 10.1080/17512433.2019.1597706. Epub 2019 Apr 24. Expert Rev Clin Pharmacol. 2019. PMID: 30916581 Review.
How plausible is an Alzheimer's disease vaccine?
Cacabelos R. Cacabelos R. Expert Opin Drug Discov. 2020 Jan;15(1):1-6. doi: 10.1080/17460441.2019.1667329. Epub 2019 Sep 17. Expert Opin Drug Discov. 2020. PMID: 31526140
Novel Therapeutic Strategies for Dementia.
Cacabelos R, Torrellas C, Carrera I, Cacabelos P, Corzo L, Fernández-Novoa L, Tellado I, Carril JC, Aliev G. Cacabelos R, et al. CNS Neurol Disord Drug Targets. 2016;15(2):141-241. doi: 10.2174/1871527315666160202121548. CNS Neurol Disord Drug Targets. 2016. PMID: 26831267 Review.
Dopaminergic Neuroprotection with Atremorine in Parkinson´s Disease.
Carrera I, Fernandez-Novoa L, Sampedro C, Tarasov VV, Aliev G, Cacabelos R. Carrera I, et al. Among authors: cacabelos r. Curr Med Chem. 2018;25(39):5372-5388. doi: 10.2174/0929867325666180410100559. Curr Med Chem. 2018. PMID: 29637853 Review.
Pharmacogenomics in Alzheimer's disease.
Cacabelos R. Cacabelos R. Methods Mol Biol. 2008;448:213-357. doi: 10.1007/978-1-59745-205-2_10. Methods Mol Biol. 2008. PMID: 18370236 Review.
97 results